Firms
Moore Strategic Ventures
Moore Strategic Ventures is the privately held investment company of Louis Bacon.
- Founded
- —
- Type
- Venture capital
Team
No team members on record yet.
Co-investing
Andreessen Horowitz
Maze Therapeutics$115M · 2024
Orbital Therapeutics$270M · 2023-04-26Workrise$300M · 2021-05-20
Workrise$300M · 2021-05-20
Workrise$300M · 2021-05-20
Workrise$300M · 2021-05-20
Workrise$300M · 2021
ARCH Venture Partners
Elephas$55M · 2024-01-23
Elephas Biosciences$55M · 2024-01-23
Maze Therapeutics$115M · 2024
Myeloid Therapeutics$73M · 2023-05-18
Orbital Therapeutics$270M · 2023-04-26
Prime Medicine, Inc.$200M · 2021-07-13
Casdin Capital
Maze Therapeutics$115M · 2024
Orbital Therapeutics$270M · 2023-04-26
Prime Medicine, Inc.$200M · 2021-07-13
Newpath Partners
Myeloid Therapeutics$73M · 2023-05-18
Orbital Therapeutics$270M · 2023-04-26
Prime Medicine, Inc.$200M · 2021-07-13
Alexandria Venture Investments
Myeloid Therapeutics$73M · 2023-05-18
Orbital Therapeutics$270M · 2023-04-26
General Catalyst
XFlow$16M · 2026-02-23
Maze Therapeutics$115M · 2024
GV
Maze Therapeutics$115M · 2024
Prime Medicine, Inc.$200M · 2021-07-13
Northpond Ventures
Elephas$55M · 2024-01-23
Elephas Biosciences$55M · 2024-01-23
Sands Capital
Elephas$55M · 2024-01-23
Elephas Biosciences$55M · 2024-01-23
8VC
Myeloid Therapeutics$73M · 2023-05-18
Activant Capital
Bolt$355M · 2022-01-14
AF Ventures
Elephas Biosciences$55M · 2024-01-23
Balderton Capital
Wayve$200M · 2022-01-18
Blackstone Inc.
Genedx$120M · 2020
Breakthrough Energy Ventures
Commonwealth Fusion Systems$115M · 2019-06-27
CE Innovation Capital
Bolt$355M · 2022-01-14
Connecticut Innovations
Genedx$120M · 2020
Cormorant Asset Management
Prime Medicine, Inc.$200M · 2021-07-13
CreditEase
Bolt$355M · 2022-01-14
D1 Capital Partners
Wayve$200M · 2022-01-18
Decheng Capital
Genedx$120M · 2020
Digital Horizon
Bolt$355M · 2022-01-14
Engine Ventures
Commonwealth Fusion Systems$115M · 2019-06-27
Eni
Commonwealth Fusion Systems$115M · 2019-06-27
F-Prime Capital
Prime Medicine, Inc.$200M · 2021-07-13
Future Fund
Commonwealth Fusion Systems$115M · 2019-06-27
Future Ventures
Commonwealth Fusion Systems$115M · 2019-06-27
H.I.G. Growth Partners
Bolt$355M · 2022-01-14
Invus Opportunities
Bolt$355M · 2022-01-14
Khosla Ventures
Commonwealth Fusion Systems$115M · 2019-06-27
Lightspeed
XFlow$16M · 2026-02-23
Lince Capital
Wayve$200M · 2022-01-18
Logos Capital
Maze Therapeutics$115M · 2024
Lowercase Capital
Commonwealth Fusion Systems$115M · 2019-06-27
PayPal Ventures
XFlow$16M · 2026-02-23
Primary Venture Partners
Myeloid Therapeutics$73M · 2023-05-18
PSP Investments
Prime Medicine, Inc.$200M · 2021-07-13
Redmile Group
Prime Medicine, Inc.$200M · 2021-07-13
Safar Partners
Commonwealth Fusion Systems$115M · 2019-06-27
Samsara BioCapital
Prime Medicine, Inc.$200M · 2021-07-13
Schonfeld Strategic Advisors
Bolt$355M · 2022-01-14
Schooner Capital
Commonwealth Fusion Systems$115M · 2019-06-27
Section 32
Genedx$120M · 2020
Square Peg Capital
XFlow$16M · 2026-02-23
Starlight Ventures
Commonwealth Fusion Systems$115M · 2019-06-27
SV Health Investors
Elephas Biosciences$55M · 2024-01-23
T. Rowe Price Associates
Prime Medicine, Inc.$200M · 2021-07-13
Tao Capital Partners
Elephas$55M · 2024-01-23
The Engine
Commonwealth Fusion Systems$115M · 2019-06-27
Vineeta Agarwala
Orbital Therapeutics$270M · 2023-04-26





